SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys. 2004; 60: 722730.
  • 2
    Arthur DW, Vicini FA, Kuske RR, Wazer DE, Nag S. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy. 2002; 1: 184190.
  • 3
    Vicini FA, Arthur DW, Wazer DE. Inconsistency, perspective, double talk, and false virtue. Brachytherapy. 2002; 1: 181183.
  • 4
    American Society of Breast Surgeons. Consensus statement for accelerated partial breast irradiation from the American Society of Breast Surgeons. Available from URL: http://www.breastsurgeons.org/officialstmts/officialstmt3.shtml [accessed April 30, 2003].
  • 5
    Pawlik TM, Perry A, Strom EA, et al. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer. 2004; 100: 490498.
  • 6
    Wazer DE, Schmidt-Ullrich RK, Schmid CH, Ruthazer R, Kramer B, Safaii H, Graham R. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden. Int J Radiat Oncol Biol Phys. 1997; 38: 291299.
  • 7
    Gwin JL, Eisenberg BL, Hoffman JP, Ottery FD, Borass M, Solin LJ. Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann Surg. 1993; 218: 729734.
  • 8
    Frazier TG, Wong RW, Rose D. Implications of accurate pathologic margins in the treatment of primary breast cancer. Arch Surg. 1989; 124: 3738.
  • 9
    Schnitt MJ, Connolly JR, Khettry U, et al. Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer. 1987; 59: 675681.
  • 10
    Smitt MC, Nowells KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long term results of breast conservation. Cancer. 1995; 76: 259267.
  • 11
    Solin LJ, Fowble B, Martz K, Pajak T, Goodman R. Results of re-excisional biopsy of the primary tumor in preparation for definitive radiation of patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1986; 12: 721725.
  • 12
    Neuschatz AC, DiPetrillo TA, Steinhoff M, et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer. 2002; 94: 19171924.
  • 13
    Goldstein NS, Kestin LL, Vicini FA. Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy. Am J Surg Pathol. 1999; 23: 13401348.
  • 14
    Schmidt-Ullrich RK, Wazer DE, Tercilla O, et al. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. Int J Radiat Oncol Biol Phys. 1989; 17: 733738.
  • 15
    Neuschatz AC, DiPetrillo TA, Safaii H, Lowther D, Landa M, Wazer DE. Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast. Int J Cancer. 2001; 96(Suppl): 97104.
  • 16
    Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor. Int J Radiat Oncol Biol Phys. 1999; 45: 885891.
  • 17
    Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 1990; 8: 113118.